Senate Republicans Considering Standalone LDT Legislation

October 9, 2015 at 2:49 PM
Legislation on government oversight of laboratory developed tests is not expected to be included in the initial draft of the Senate health committee's Innovation for Healthier Americans bill, the chamber's counter-part to the House-passed 21st Century Cures measure, lobbyist sources told Inside Health Policy . Instead, Republican senators engaged on the issue are looking at pushing a standalone bill that is expected to propose updating the current CMS oversight framework for laboratories. As House lawmakers consider a revised proposal from...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.